MEMORIA CIENTIFICA 2020

Servicio de Dermatología.

Hospital Universitario San Cecilio

 

PUBLICACIONES

 

Dermatología General

 

  1. Cuenca-Barrales C, Molina-Leyva A. Risk Factors of Sexual Dysfunction in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study. Dermatology. 2020;236(1):37-45.
  2. Molina-Leyva A, Cuenca-Barrales C. Pruritus and Malodour in Patients with Hidradenitis Suppurativa: Impact on Quality of Life and Clinical Features Associated with Symptom Severity. Dermatology. 2020;236(1):59-65.
  3. Montero-Vilchez T, Martinez-Lopez A, Cuenca-Barrales C, Martin-Castro A, Molina-Leyva A, Arias-Santiago S. Nodular lichen myxoedematous: a new adverse event associated with ustekinumab. Australas J Dermatol. 2020 Aug;61(3):e344-e345.
  4. Cuenca-Barrales C, Salvador-Rodríguez L, Arias-Santiago S, Molina-Leyva A. Pre-operative ultrasound planning in the surgical management of patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2362-2367.
  5. Cuenca-Barrales C, Montero-Vílchez T, Szepietowski JC, Matusiak L, Molina-Leyva A. Sexual impairment in patients with hidradenitis suppurativa: a systematic review. J Eur Acad Dermatol Venereol. 2020 Jun 12.
  6. Salvador-Rodriguez L, Cuenca-Barrales C, Arias-Santiago S, Molina-Leyva A. Neoadjuvant Biologic Therapy in the Surgical Management of Patients with Hidradenitis Suppurativa: A Cohort Study. Acta Derm Venereol. 2020 Sep 8;100(16):adv00257.
  7. Martinez-Lopez A, Cuenca-Barrales C, Montero-Vilchez T, Molina-Leyva A, Arias-Santiago S. Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist. J Am Acad Dermatol.2020 Dec;83(6):1738-1748.
  8. Montero-Vilchez T, Salvador-Rodriguez L, Sanchez-Diaz M, Cuenca-Barrales C, Martinez-Lopez A, Arias-Santiago S, Molina-Leyva A. Clinical selection criterio in new clinical trials of hidradenitis suppurativa: External validity and implications on the daily clinical practice. Dermatol Ther. 2020 Aug 29:e14254.
  9. Cuenca-Barrales C, Molina-Leyva A, Arias-Santiago S. Potential role of human allogeneic mesenchymal cells in the treatment of refractory fistulas in patients with hidradenitis suppurativa. Dermatol Ther. 2020 Nov 16.
  10. Garcia Castro R, Viñolas-Cuadros A, Moyano-Bueno D, Conde-Ferreiros A, Cardeñoso E, Santos-Briz A. Pseudolymphomatous Atypical Fibroxanthoma. Am J Dermatopathol. 2020 Aug 4.
  11. Santos-Briz A, Medina-Miguelañez M, Moyano-Bueno D, Viñolas-Cuadros A,Martínez TG, Izquierdo MM, García-Sánchez MS. Indeterminate Dendritic Cell Tumor as Cutaneous Involvement of Chronic Myelomonocytic Leukemia Successfully Treated With Phototherapy. Am J Dermatopathol. 2020 Nov;42(11):876-880.
  12. Gómez-Lechón Quirós L, Acosta De La Vega ME, Compán Fernández O, Pastor Navarro S, Montilla Morales C, Moyano Bueno D, Martín Centellas J, Santos-Briz Terrón A, Hidalgo Calleja C. Crystalglobulinemia manifested as acute renal failure and thrombotic vasculopathy. Rheumatol Int. 2020 Aug;40(8):1327-1332.
  13. Navarro Triviño FJ, Linares González L, Rodenas Herranz T. A "Cesarean Scar" - With No C-Section! Actas Dermosifiliogr. 2020 Oct 16:S0001-7310(20)30412-9.
  14. Navarro-Triviño FJ, Moreno-Higueras M. Keratoderma and dental involvement. Rev Clin Esp. 2020 Jul 18:S0014-2565(20)30171-5.
  15. Navarro-Triviño FJ, Muñoz-Valera MT, Callejas-Rubio JL, Ortego-Centeno N. Systemic sarcoidosis successfully treated with adalimumab: A case report.Dermatol Ther. 2020 May;33(3):e13422.
  16. Navarro-Triviño FJ. Neutrophilic dermatosis and myelodysplastic syndrome. Med Clin (Barc). 2020 Jan 24;154(2):73.
  17. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, González-Ruiz L, Ayén Á, Lenouvel D, Ruiz-Ávila I, Ramos-García P. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2020 Mar 7.
  18. Ruiz-Villaverde R, Llamas-Molina JM, Navarro-Triviño FJ. sQUIZ your knowledge! A blue-coloured nodule on the abdomen. Eur J Dermatol. 2020 Oct 1;30(5):639-641.
  19. Vega-Castillo JJ, Cuenca-Barrales C, Ruiz-Villaverde R. sQUIZ your knowledge! Palmoplantar eruption in a patient with arthralgia and bilateral eye redness.Eur J Dermatol. 2020 Oct 1;30(5):631-632
  20. Ruiz-Villaverde R, García-Lara GM, Llamas-Molina JM, Ayén-Rodriguez A. A skin ulcer may be a clue to rule out the Blue Whale Challenge. Int J Dermatol. 2020 Nov 9.
  21. Linares-Gonzalez L, Ródenas-Herranz T, Galvez-Moreno M, Ruiz-Villaverde R. Eruptive Keratoacanthomas in a Red Tattoo. Sultan Qaboos Univ Med J. 2020 Aug;20(3):e372-e373.
  22. Vega-Castillo JJ, Sáenz-Guirado S, Ruiz-Villaverde R. Villar Nodule: AnUmbilical Nodule Associated With a Good Prognosis. Actas Dermosifiliogr. 2020 Oct 10:S0001-7310(20)30376-8.
  23. Ayén-Rodriguez A, Ruiz-Villaverde R. Visual Dermatology: Dermatosis Neglecta or Unwashed Dermatosis. J Cutan Med Surg. 2020 Sep/Oct;24(5):518.
  24. Ródenas-Herranz T, Linares-González L, Carpena-Martínez I, Pérez-Ramos M, Ruiz-Villaverde R. Cutaneous leishmaniasis induced by TNF-α blockers: a diagnostic challenge. Int J Dermatol. 2020 Sep 29.
  25. Navarro-Triviño FJ, Aneiros-Fernández J, Ruiz-Villaverde R. Derbe asymptomatische Papeln und Knoten auf der Kopfhaut. J Dtsch Dermatol Ges. 2020 Sep;18(9):1046-1049.
  26. Ródenas-Herranz T, Ayén-Rodriguez A, Llamas-Molina JM, Ruiz-Villaverde R. Penfigoide ampolloso sobre herida quirúrgica. ¿Una complicación emergente en el anciano? [Bullous pemphigoid over a surgical wound. An emerging complication in the elderly?]. Aten Primaria. 2020 Sep 21:S0212-6567(20)30206-7.
  27. Ruiz-Villaverde R, Ayen-Rodriguez A, Llamas-Molina JM. sQuiz your knowledge: Polycyclic annular plaques on the trunk following dutasteride treatment. Eur J Dermatol. 2020 Aug 1;30(4):452-453.
  28. Navarro-Triviño FJ, Llamas-Molina JM, Ayen-Rodriguez A, Cancela-Díez B, Ruiz-Villaverde R. Dramatic improvement of bullous pemphigoid with omalizumab in an elderly patient. Eur J Hosp Pharm. 2020 Sep 12:ejhpharm-2020-002418.
  29. Llamas-Molina JM, Ayén-Rodriguez A, Ruiz-Villaverde R. Hemangioma hemosiderótico en diana: una dermoscopia fácilmente identificable [Haemosiderotic hemangioma on target: An easily identifiable dermoscopy]. Semergen. 2020 Aug 20:S1138-3593(20)30248-3.
  30. Pérez-López I, Ródenas-Herranz T, Ruiz-Villaverde R. Hereditary leiomyomatosis associated with renal cell carcinoma. Med Clin (Barc). 2020 Aug 14:S0025-7753(20)30537-6.
  31. Ródenas-Herranz T, Linares-Gonzalez L, Muñoz-Medina L, Ruiz-Villaverde R. Clinically atypical cutaneous mycobacteriosis: A therapeutic challenge. Dermatol Ther. 2020 Aug 14:e14184.
  32. Vega-Castillo JJ, Ruiz-Villaverde R. Nódulos eritematosos palpebrales bilaterales [Bilateral palpebral erythematous nodules]. Aten Primaria. 2020 Oct;52(8):574-575.
  33. Català A, Galván-Casas C, Carretero-Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa A, Navarro-Fernández Í, Ruiz-Villaverde R, Falkenhain-López D, Llamas-Velasco M, Carnero-Gonzalez L, García-Gavin J, Baniandrés O, González-Cruz C, Morillas-Lahuerta V, Cubiró X, Figueras I, Selda- Enriquez G, Fustà-Novell X, Roncero-Riesco M, Burgos-Blasco P, Romaní J, Solà- Ortigosa J, García-Doval I. Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study. Dermatol Ther. 2020 Aug 10:e14170.
  34. Linares-González L, Ródenas-Herranz T, Vera-Álvarez S, Ruiz-Villaverde R. Massive painful parietal necrosis. Med Clin (Barc). 2020 Jul 24:S0025-7753(20)30386-9.
  35. Navarro-Triviño FJ, Aneiros-Fernández J, Ruiz-Villaverde R. Hard asymptomatic papules and nodules on the scalp. J Dtsch Dermatol Ges. 2020 Sep;18(9):1046-1049.
  36. Pereyra-Rodriguez JJ, Galán Gutiérrez M, Armario-Hita JC, Ruiz-Villaverde R. Prevalence of chronic urticaria refractory to antihistamines in Andalucia, Spain. Dermatol Ther. 2020 Jun 18:e13866.
  37. Ayén-Rodriguez A, Navarro-Triviño F, Ruiz-Villaverde R. sQUIZ your Knowledge: Rapidly growing violaceous nodules on the left foot in an immunocompetent elderly man. Eur J Dermatol. 2020 Apr 1;30(2):222-223.
  38. Ruiz-Villaverde R, Armario-Hita JC, Dominguez-Cruz J, Pereyra-Rodriguez JJ. The Safety of Dupilumab in Clinical Practice: 52 Weeks of Experience at 5 Referral Hospitals in Andalusia. Actas Dermosifiliogr. 2020 Oct;111(8):699-700.
  39. Ródenas-Herranz T, Mercader-Garcia P, Navarro-Triviño FJ, Ruiz-Villaverde R.Scleredema and nodal inflammatory pseudotumor: IgG4-related disease? Int J Dermatol. 2020 Jun 12. doi: 10.1111/ijd.14995.
  40. Ruiz-Villaverde R, Sánchez-Cano D, Martín-Perez AJ, Navarro-Triviño F.Adalimumab induced chilblain lupus in a patient with rheumatoid arthritis. Dermatol Ther. 2020 Jul;33(4):e13764.
  41. Ródenas-Herranz T, Linares-Gonzalez L, Ruiz-Villaverde R. RF – Diagnostic Biopsy for Amyloidosis: Subcutaneous Fat or Minor Salivary Gland? Actas Dermosifiliogr. 2020 Jul-Aug;111(6):520-521.
  42. Ródenas-Herranz T, Sánchez-Cano D, Linares-Gonzalez L, Ruiz-Villaverde R. Capecitabine-induced bilateral ectropion on a patient with paraneoplastic dermatomyositis. Dermatol Ther. 2020 Jul;33(4):e13772.
  43. Ródenas-Herranz T, Linares-Gonzalez L, Aneiros-Fernández J, Ruiz-Villaverde R. RF- Melanoma and Tattoos. An Association Under Debate. Actas Dermosifiliogr. 2020 Jul-Aug;111(6):518-519.
  44. Navarro-Triviño FJ, Pérez-López I, Ruiz-Villaverde R. Doxycycline, an Antibiotic or an Anti-Inflammatory Agent? The Most Common Uses in Dermatology. Actas Dermosifiliogr. 2020 Sep;111(7):561-566.
  45. Galán-Gutierrez M, Gomez-Arias PJ, Rodenas-Herranz T, Ruiz-Villaverde R. Autoimmune progesterone dermatitis: Successful outcome with bilateral salpingo- oophorectomy. Dermatol Ther. 2020
  46. Garcia-Lara G, Linares-González L, Ródenas-Herranz T, Ruiz-Villaverde R. Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak. Dermatol Ther. 2020 May 6:e13516.
  47. Ródenas-Herranz T, Linares-González L, Rojo-España R, Ruiz-Villaverde R. Pancreas-kidney transplantation resolves chronic necrobiosis lipoidica: A case report. Dermatol Ther. 2020 Jul;33(4):e13484.
  48. Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, Navarro Fernández I, Ruiz-Villaverde R, Falkenhain-López D, Llamas Velasco M, García-Gavín J, Baniandrés O, González- Cruz C, Morillas-Lahuerta V, Cubiró X, Figueras Nart I, Selda-Enriquez G, Romaní J, Fustà-Novell X, Melian-Olivera A, Roncero Riesco M, Burgos-Blasco P, Sola Ortigosa J, Feito Rodriguez M, García-Doval I. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020 Jul;183(1):71-77.
  49. Navarro-Triviño FJ, Ródenas-Herranz T, Ramos-Pleguezuelos FM, Ruíz- Villaverde R. Multiple eruptive Plaques auf der Kopfhaut. J Dtsch Dermatol Ges. 2020 Apr;18(4):384-387.
  50. Navarro-Triviño FJ, Ródenas-Herranz T, Ramos-Pleguezuelos FM, Ruíz- Villaverde R. Multiple eruptive plaques on the scalp. J Dtsch Dermatol Ges. 2020 Apr;18(4):384-387.
  51. Navarro-Triviño FJ, Almazán-Fernández FM, Ródenas-Herranz T, Ruiz-Villaverde R. Dissecting cellulitis of the scalp successfully treated with topical resorcinol 15. Dermatol Ther. 2020 May;33(3):e13406.
  52. Rodenas-Herranz T, Linares-Gonzalez L, Martinez-Velez V, Ruiz-Villaverde R. Hookworm-related cutaneous larva migrans successfully treated with topical ivermectin 0.1. Dermatol Ther. 2020 May;33(3):e13316
  53. Alcántara Villar M, Armario Hita JC, Cimbollek S, Fernández Ballesteros MD, Galán Gutiérrez M, Hernández Montoya C, Lara-Jiménez MÁ, Pereyra Rodríguez JJ, Vega Chicote JM, Ruiz-Villaverde R. A Review of the Latest Recommendations on the Management of Chronic Urticaria: A Multidisciplinary Consensus Statement from Andalusia, Spain. Actas Dermosifiliogr. 2020 Apr;111(3):222-228.
  54. Cuenca-Barrales C, Navarro-Triviño FJ, Espadafor-López B, Arias-Santiago SA, Ruiz-Villaverde R. Zosteriform Metastases From Eccrine Porocarcinoma. Actas Dermosifiliogr. 2020 Apr;111(3):276-278.
  55. Navarro-Triviño FJ, Linares-Gonzalez L, Ródenas-Herranz T, Ruiz-Villaverde R. Successful treatment of micaceous balanitis with 5% topical imiquimod: case report and review of the literature. Int J Dermatol. 2020 Jun;59(6):e199-e201.
  56. Navarro-Triviño FJ, Sanchez-Parera R, Ruiz-Villaverde R. Secukinumab-induced paradoxical hidradenitis suppurativa. Dermatol Ther. 2020 Jan;33(1):e13150.
  57. Pérez-López I, Herrera-García JD, Ruiz-Villaverde R. Palmar hyperkeratosis in an immunodeficient patient. Med Clin (Barc). 2020 Sep 25;155(6):279.
  58. Cuenca-Barrales C, Espadafor-Lopez B, Ruiz-Villaverde R. Majocchís granuloma on the genital area. J Obstet Gynaecol. 2020 Apr;40(3):438-439.
  59. Espadafor-López B, Cuenca-Barrales C, Salvador-Rodriguez L, Ruiz-Villaverde R. Iatrogenic Kaposi's Sarcoma Successfully Treated with Topical Timolol. Actas Dermosifiliogr. 2020 Mar;111(2):176-178.
  60. Navarro-Triviño FJ, Ruíz-Villaverde R. Yellow keratotic palmoplantar papules and chronic abdominal pain. Rev Clin Esp. 2020 Jun-Jul;220(5):317-318.
  61. Navarro-Triviño FJ, González-Ruiz L, Ruíz-Villaverde R. Flower and Milium: A Tatoo With Points in Relief. Actas Dermosifiliogr. 2020 Mar;111(2):164.
  62. Ródenas-Herranz T, Linares-Gonzalez L, Ruiz-Villaverde R. IgG4-Related Disease 4 Years On. Actas Dermosifiliogr. 2020 Nov 27:S0001-7310(20)30509-3.
  63. Ródenas-Herranz T, Ayén-Rodriguez A, Llamas-Molina JM, Ruiz-Villaverde R. Penfigoide ampolloso sobre herida quirúrgica. ¿Una complicación emergente en el anciano? [Bullous pemphigoid over a surgical wound. An emerging complication in the elderly?]. Aten Primaria. 2021 Jan;53(1):104-106.

Unidad de Terapia Fotodinamica

 

  1. Linares-González L, Ródenas-Herranz T, Sáenz-Guirado S, Ruiz-Villaverde R. Successful response to photodynamic therapy with 5-aminolevulinic acid nanoemulsified gel in a patient with universal alopecia areata refractory to conventional treatment. Dermatol Ther. 2020 May;33(3):e13416.
  2. Navarro-Triviño FJ, Ayén-Rodríguez Á, Llamas-Molina JM, Saenz-Guirado S, Ruiz-Villaverde R. Treatment of superficial Basal Cell Carcinoma with 7.8% 5-aminolaevulinic acid % nanoemulsion-based gel (BF-200 ALA) and Photodynamic Therapy: results in clinical practice in a Tertiary Hospital. Dermatol Ther. 2020 Nov 19:e14558.

 

Unidad de Dermatologia Pediátrica

 

  1. Navarro-Triviño FJ, Pérez-López I, Ruiz-Villaverde R. Unilateral laterothoracic exanthema. J Pediatr. 2020 Sep 18:S0022-3476(20)31166-5.
  2. Cuenca-Barrales C, Monserrat-García MT, Domínguez-Cruz JJ, Suñol-Capella M, Zulueta-Dorado T, Fernández R, Mascaró JM, Vicente A, Bernabéu-Wittel J. Ectodermal dysplasia-skin fragility syndrome: two new cases with a novel missense mutation. J Dtsch Dermatol Ges. 2020 Oct 30.

Unidad de Melanoma y Oncologia Cutánea

 

  1. Palacios-Ferrer JL, García-Ortega MB, Gallardo-Gómez M, García MÁ, Díaz C, Boulaiz H, Valdivia J, Jurado JM, Almazan-Fernandez FM, Arias-Santiago S, Amezcua V, Peinado H, Vicente F, Pérez Del Palacio J, Marchal JA. Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma. Mol Oncol. 2020 Oct 14. doi: 10.1002/1878-0261.12823.
  2. Tejera-Vaquerizo A, Cañueto J, Toll A, Santos-Juanes J, Jaka A, Ferrandiz-Pulido C, Sanmartín O, Ribero S, Moreno-Ramírez D, Almazán F, Fuente MJ, Podlipnik S, Nagore E. Estimación del efecto en el tamaño y la supervivencia de los tumores cutáneos debido al confinamiento por COVID-19: modelo basado en un crecimiento exponencial [Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model]. Actas Dermosifiliogr. 2020 Oct;111(8):629-638.
  3. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, González-Ruiz L, Ayén Á, Lenouvel D, Ruiz-Ávila I, Ramos-García P. Clinical interpretation of findings from a systematic review and a comprehensive meta-analysis on clinicopathological and prognostic characteristics of oral squamous cell carcinomas (OSCC) arising in patients with oral lichen planus (OLP): Author's reply. Oral Oncol. 2020 Oct 8:105036.
  4. González-Moles MÁ, Ayén Á, González-Ruiz I, de Porras-Carrique T, González- Ruiz L, Ruiz-Ávila I, Ramos-García P. Prognostic and Clinicopathological Significance of FADD Upregulation in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Cancers (Basel). 2020 Aug 24;12(9):2393.
  5. Áyen Á, Jiménez Martínez Y, Boulaiz H. Targeted Gene Delivery Therapies for Cervical Cancer. Cancers (Basel). 2020 May 21;12(5):1301.
  6. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, González-Ruiz L, Ayén Á, Lenouvel D, Ruiz-Ávila I, Ramos-García P. Clinicopathological and prognostic characteristics of oral squamous cell carcinomas arising in patients with oral lichen planus: A systematic review and a comprehensive meta-analysis. Oral Oncol. 2020 Jul;106:104688.
  7. González-Ruiz L, González-Moles MÁ, González-Ruiz I, Ruiz-Ávila I, Ayén Á, Ramos-García P. An update on the implications of cyclin D1 in melanomas. Pigment Cell Melanoma Res. 2020 Nov;33(6):788-805.
  8. Ramirez-Moreno E, Lozano-Lozano M, O'Valle Ravassa F, Ramirez-Tortosa C, Ruiz-Villaverde R. Expression of IMP3 in a retrospective cohort of melanomas with selective lymph node biopsy. Dermatol Ther. 2020 Oct 19:e14413. doi: 10.1111/dth.14413. Epub ahead of print. PMID: 33073451.

 

Unidad de Fototerapia

 

  1. Ruiz-Villaverde R, Espelt-Otero JL, Linares-Gonzalez L. Multiple xanthogranuloma in an adult: Succesful response to UVA-1 therapy. Dermatol Ther. 2020 Jun 25:e13892.
  2. Espelt-Otero J, Ayen-Rodriguez A, Linares-Gonzalez L, Sánchez-Cano D, Ruiz-Villaverde R. Idiopathic erythroderma refractory to conventional treatment. Successful response to UVA1. Dermatol Ther. 2020 May;33(3):e13340.
  3. Linares-Gonzalez L, Ródenas-Herranz T, Espelt-Otero JL, Ruiz-Villaverde R. Buschke Sclerederma Refractory to Conventional Treatment: Response to UV-A1 Phototherapy. Actas Dermosifiliogr. 2020 Nov 27:S0001-7310(20)30507-X.

 

Unidad de Inmunoalergia

 

  1. Navarro-Triviño FJ, Ruiz-Villaverde R. Periocular allergic contact dermatitis caused by brinzolamide. Contact Dermatitis. 2020 Oct 22.
  2. Navarro-Triviño FJ, Naranjo-Diaz MJ, Ruiz-Villaverde R. Cutaneous lymphoid hyperplasia caused by cosmetic lip tattoo successfully treated with tacrolimus 0.1% ointment. Contact Dermatitis. 2020 Oct 20.
  3. Navarro-Triviño FJ, Ruiz-Villaverde R. Photoallergic contact cheilitis from methylchloroisothiazolinone/methylisothiazolinone: Where is the culprit product?. Contact Dermatitis. 2020 Sep 23.
  4. Navarro-Triviño FJ, Ruiz-Villaverde R. Phototoxic eruption caused by enzalutamide (Xtandi). Contact Dermatitis. 2020 Aug 31.
  5. Navarro-Triviño FJ, Ruiz-Villaverde R. Allergic contact dermatitis to eyeglass frame nosepiece caused by tetraethylthiuram disulphide and resorcinol monobenzoate. Int J Dermatol. 2020 Aug 6.
  6. Navarro-Triviño FJ, Ruiz-Villaverde R. Allergic contact dermatitis caused by surgical mesh after umbilical hernia surgery. Contact Dermatitis. 2020 Jul 25.
  7. Navarro-Triviño FJ, Jadczak P, Ruiz-Villaverde R. Allergic contact dermatitis caused by Lavandula angustifolia and cross-reaction with Citrus bergamia essential oils in an aromatherapist. Int J Dermatol. 2020 Jul 2. doi:
  8. Navarro-Triviño FJ, Ruiz-Villaverde R. Therapeutic approach to skin reactions caused by personal protective equipment (PPE) during COVID-19 pandemic: An experience from a tertiary hospital in Granada, Spain. Dermatol Ther. 2020 Jun 15:e13838.
  9. Navarro-Triviño FJ, Ruiz-Villaverde R. Allergic contact dermatitis caused by caprylic/capric triglyceride from an anti-aging cosmetic cream. Contact Dermatitis. 2020 Jun 15.
  10. Navarro-Triviño FJ, Ruiz-Villaverde R. Contact urticaria/angioedema caused by nickel from metal dental braces. Contact Dermatitis. 2020 Nov;83(5):425-427.
  11. Navarro-Triviño FJ, Almazán-Fernández FM, Ruiz-Villaverde R. Allergic contact urticaria caused by Essure®. Int J Dermatol. 2020 Sep;59(9):1165-1167.
  12. Navarro-Triviño FJ, Merida-Fernández C, Ródenas-Herranz T, Ruiz-Villaverde R. Allergic contact dermatitis caused by elastic bands from FFP2 mask. Contact Dermatitis. 2020 Aug;83(2):168-169.
  13. Navarro-Triviño FJ, Ruiz-Villaverde R. Photoallergic systemic dermatitis caused by sorbitan monooleate in craft beer. Contact Dermatitis. 2020 Sep;83(3):230-232.
  14. Navarro-Triviño FJ, Ruiz-Villaverde R. Allergic contact dermatitis caused by 2-ethylhexyl acrylate in a rivastigmine transdermal therapeutic system. Contact Dermatitis. 2020 Aug;83(2):143-145.
  15. Navarro-Triviño FJ, Ruiz-Villaverde R. Purpuric contact dermatitis caused by N-isopropyl-N'-phenyl-p-phenylenediamine from a Samsung Fit strap. Contact Dermatitis. 2020 Jul;83(1):68-69.
  16. Navarro-Triviño FJ, Navarro-Rivero PM, Ruiz-Villaverde R. A case report of oral lichenoid lesions. Are patch tests necessary? Contact Dermatitis. 2020 Jul;83(1):59-61.
  17. Navarro-Triviño FJ, Natalia C, Ruiz-Villaverde R. Eczema-like infection caused by a new emerging pathogen: Rhodotorula mucilaginosa. Int J Dermatol. 2020 Aug;59(8):e305-e306.
  18. Navarro-Triviño FJ, Ruiz-Villaverde R. Allergic contact dermatitis of head and neck by propolis contained in a shampoo. Contact Dermatitis. 2020 Jun;82(6):409-410.
  19. Navarro-Triviño FJ, Sierra Cerdán MJ, Ruiz-Villaverde R. Tegaderm<sup>TM</sup> I.V. Advanced can prevent eczematous reaction caused by Dexcom glucose monitoring system. Int J Dermatol. 2020 May;59(5):e166-e168.
  20. Navarro-Triviño FJ, Cuenca-Manteca J, Ruiz-Villaverde R. Allergic contact dermatitis with systemic symptoms caused by VenaSeal. Contact Dermatitis. 2020 Mar;82(3):185-187.
  21. Navarro-Triviño FJ, Ruiz-Villaverde R. Allergic contact dermatitis of the hands caused by thiurams in bicycle cuffs. Contact Dermatitis. 2020 Mar;82(3):176-177.
  22. Navarro-Triviño FJ, Ruiz-Villaverde R. Chronic foot eczema caused by Bis-GMA from composite work protection boots. Contact Dermatitis. 2020Mar;82(3):167-168.
  23. Ródenas-Herranz T, Navarro-Triviño FJ, Linares-González L, Ruiz-Villaverde R, Brufau-Redondo C, Mercader-García P. Acrylate allergic contact dermatitis caused by hair prosthesis fixative. Contact Dermatitis. 2020 Jan;82(1):62-64.

 

Unidad de Psoriasis

 

  1. Navarro-Triviño FJ, Ruiz-Villaverde R. Successful treatment of erythematous-squamous disorders of the external auditory canal with tacrolimus and clotrimazole in otic oil: Our experience in 25 patients. Dermatol Ther. 2020 Oct 28:e14471.
  2. Ruiz-Villaverde R, Galán-Gutierrez M, Carlos Armario-Hita J, Ruiz-Carrascosa JC, Font-Ugalde P. Brodalumab: short-term effectiveness and safety in real clinical practice. Int J Dermatol. 2020 Sep;59(9):e340-e341.
  3. Ruiz-Villaverde R, Ayén-Rodriguez A, Llamas-Molina JM, Ruiz-Carrascosa JC. Risankizumab as a promising therapeutic approach in obese patients. Dermatol Ther. 2020 May;33(3):e13323.
  4. Aguayo-Carreras P, Ruiz-Carrascosa JC, Molina-Leyva A. Type D personality is associated with poor quality of life, social performance, and psychological impairment in patients with moderate to severe psoriasis: A cross-sectional study of 130 patients. Indian J Dermatol Venereol Leprol. 2020 Jul-Aug;86(4):375-381.
  5. Ruiz-Villaverde R, Rodríguez Fernández-Freire L, Galán-Gutiérrez M, Armario- Hita JC, Martinez-Pilar L. Secukinumab: Drug Survival in Clinical Practice Settings. Actas Dermosifiliogr. 2020
  6. Belinchón I, Velasco M, Ara-Martín M, Armesto Alonso S, Baniandrés Rodríguez O, Ferrándiz Pulido L, García-Bustinduy M, Martínez-López JA, Martínez Sánchez N, Pérez Ferriols A, Pérez Pascual E, Rivera Díaz R, Ruiz-Villaverde R, Taberner Ferrer R, Vicente Villa A, Carrascosa JM. Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus Statement. Actas Dermosifiliogr. 2020 Oct 13:S0001-7310(20)30408-7.
  7. Rivera R, Velasco M, Vidal D, Carrascosa JM, Daudén E, Vilarrasa E, NotarioJ, Ruíz-Villaverde R, Yanguas I, García-Latasa FJ, Ferrán M, Lázaro-Simó A, dela Cueva P, Salgado-Boquete L, Belinchón I. The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study. Dermatol Ther. 2020 Jul 25:e14066.
  8. Ruiz-Villaverde R, Galán-Gutierrez M. Biosimilars in psoriasis: what shouldyour positioning be? Expert Opin Biol Ther. 2020 Jul 27:1-6.
  9. Del Alcázar E, Suárez-Pérez JA, Armesto S, Rivera R, Herrera-Acosta E, Herranz P, Martín I, Montesinos E, Hospital M, Vilarrasa E, Ferran M, Ruiz- Villaverde R, Sahuquillo-Torralba A, Ruiz-Genao DP, Pérez-Barrio S, Muñoz C, Llamas M, Valentí F, Mitxelena MJ, López-Ferrer A, Carretero G, Vidal D, Mollet J, Belinchón I, Carrascosa JM. Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group. J Eur Acad Dermatol Venereol. 2020 Apr 9.
  10. Rodriguez Fernandez-Freire L, Galán-Gutierrez M, Armario-Hita JC, Perez-Gil A, Ruiz-Villaverde R. Guselkumab: Short-term effectiveness and safety in real clinical practice. Dermatol Ther. 2020 May;33(3):e13344.
  11. Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Galán-Gutierrez M, Armario- HIta JC, Martinez-Pilar L. Drug survival, discontinuation rates, and safety profile of secukinumab in real-world patients: a 152-week, multicenter, retrospective study. Int J Dermatol. 2020 May;59(5):633-639.
  12. Cañete JD, Nolla JM, Queiro R, Rodríguez MJ, Ruiz M, Lizán L; MERECES Working Group. Expert Consensus on a Set of Outcomes to Assess the Effectiveness of Biologic Treatment in Psoriatic Arthritis: The MERECES Study. J Rheumatol. 2020 Nov 1;47(11):1637-1643.
  13. Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Galán-Gutierrez M, Martinez- Pilar L. Efficacy of secukinumab in psoriasis and psoriatic arthritis: A retrospective multicentre study. Med Clin (Barc). 2020 May 8;154(9):370-371.

 

ENSAYOS CLINICOS ACTIVOS

 

Título: A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis. ClinicalTrials.gov.Identifier: NCT03569293

Carácter: Europeo

Laboratorio responsable: Abbvie SA

Investigador principal: Jose C Ruiz Carrascosa

Investigador colaborador: Ricardo Ruiz Villaverde

 

Título: A randomized double-blind placebo-controlled study evaluating the effect of dupilumab on sleep in adult patients with moderate to severe atopic dermatitis

Product Code: SAR231893

Dupilumab Study Code / Name: LPS15497

Co-investigadores: Jose Carlos Ruiz Carrascosa

Carácter: Europeo

Laboratorio responsable: Sanofi

Investigador principal Local: Ricardo Ruiz Villaverde

 

Título: Estudio fase 4 de comparación y eficacia y seguridad de Brodalumab versus guselkumab en sujetos adultos con psoriasis en placas de moderada a grave y respuesta inadecuada a ustekinumab. Estudio cobra.*

EudraCT: LP0160—510

Investigador principal: Jose Carlos Ruiz Carrascosa

Co-investigador: Ricardo Ruiz-Villaverde

Laboratorio responsable: Leo

Nº centro: ESP1493

 

Título:  ‘An international, multicentre, open label, interventional phase IV clinical study to investigate the efficacy and safety of tildrakizumab 100 mg in patients with moderate-to-severe chronic plaque psoriasis and its impact on their quality of life’.

Código del protocolo: M-14745-42 /EudraCT: 2019-002804-42

Promotor: Almirall

Investigador principal: Jose Carlos Ruiz Carrascosa

Co-investigador: Ricardo Ruiz-Villaverde

 

 

ESTUDIOS OBSERVACIONALES NO EPA EN ACTIVO

 

Unidad de Terapia Fotodinámica

 

Terapia Fotodinámica convencional vs Terapia Fotodinámica Luz de Día + Terapia Fotodinámica Convencional

Promotor: Servicio de Dermatología. Hospital Universitario Clínico San Cecilio

FEA. Soledad Saénz Guirado

 

Tratamiento del Carcinoma Basocelular superficial con Terapia Fotodinámica con Luz Roja LED 365 nm y BF 200 ALA. Estudio prospectivo, abierto, no controlado con placebo.

Promotor: Servicio de Dermatología. Hospital Universitario Clínico San Cecilio

FEA: Francisco J Navarro Triviño

Publicado: Navarro-Triviño FJ, Ayén-Rodríguez Á, Llamas-Molina JM, Saenz-Guirado S, Ruiz-Villaverde R. Treatment of superficial Basal Cell Carcinoma with 7.8% 5-aminolaevulinic acid % nanoemulsion-based gel (BF-200 ALA) and Photodynamic Therapy: results in clinical practice in a Tertiary Hospital. Dermatol Ther. 2020 Nov 19:e14558. doi: 10.1111/dth.14558. Epub ahead of print. PMID: 33210436.

 

Unidad de Melanomas/Oncología cutánea

 

Sintomatología asociada a la BSGC

Promotor: Servicio de Dermatología. Hospital Universitario Clínico San Cecilio

FEA: Francisco Almazán Fernández

 

Estudio de la demora en el diagnóstico y tratamiento del cáncer de piel y el impacto en la carga tumoral por el confinamiento por el COVID-19

Promotor: Antonio Tejera Vaquerizo. AEDV

FEA: Francisco Almazán Fernández/Teresa Ródenas Herranz

Concluido

 

Dermatología General

 

Caracterización histología y molecular de la matriz extracelular en la AAF. Estudio prospectivo, abierto, no controlado

Promotor: Servicio de Dermatología. Hospital Universitario Clínico San Cecilio

FEA: Ricardo Ruiz Villaverde y Francisco J Navarro Triviño

 

Tratamiento de dermatosis eritemato-escamosas localizadas en pabellón auricular y conducto auditivo externo con formulación magistral de Tacrolimus 0.1% + Clotrimazol 1% en aceite ótico. Estudio prospectivo, abierto, no controlado con placebo.

Promotor: Servicio de Dermatología. Hospital Universitario Clínico San Cecilio

FEA: Francisco J Navarro Triviño

Navarro-Triviño FJ, Ruiz-Villaverde R. Successful treatment of erythematous-squamous disorders of the external auditory canal with tacrolimus and clotrimazole in otic oil: Our experience in 25 patients. Dermatol Ther. 2020 Oct 28:e14471. doi: 10.1111/dth.14471. Epub ahead of print. PMID: 33112026.

 

Descripción de las manifestaciones cutáneas de Covid-19

Promotor: Fundacion Piel Sana. AEDV

FEA: Ricardo Ruiz Villaverde

Concluido y publicado en BJD: Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases [published online ahead of print, 2020 Apr 29]. Br J Dermatol. 2020;10.1111/bjd.19163. doi:10.1111/bjd.19163

 

Global cross-sectional burden of illness study in adolescent and adult patients with atopic dermatitis (Measure)

Promotor: Abbvie SA

FEA: Ricardo Ruiz Villaverde/Jose Carlos Ruiz Carrascosa

 

Estudio multicéntrico sobre los patrones ecográficos de las metástasis cutáneas

Promotor: Clínica Universitaria de Navarra

FEA: Ricardo Ruiz Villaverde

 

Estudio multicéntrico epidemiológico observacional y descriptivo de casos y controles sobre la dermatomiositis asociada a anticuerpos antiMDA-5.

Investigador principal: María Castellanos González. Dermatóloga Hospital del Sureste.

FEA: Ricardo Ruiz Villaverde

 

 

Unidad de Psoriasis

 

Estudio observacional para determinar la utilidad de la escala PA-SPGA-G para la evaluación de la gravedad subjetiva de la psoriasis genital

Promotor: Servicio Dermatología. Complejo Hospitalario de Pontevedra

FEA: Ricardo Ruiz Villaverde

 

Estudio PsOR-ELLAs. Percepción de la mujer con psoriasis en la planificación familiar

Promotor: Servicio Dermatología. Hospital Ramon y Cajal de Madrid. Ucb Pharma

FEA: Ricardo Ruiz Villaverde/ Jose Carlos Ruiz Carrascosa

 

 

Estudio Qalipso. Estudio Observacional prospectivo para evaluar la calidad de vida en pacientes con psoriasis en placas tratados con Enstilar por primera vez.

Promotor:  LEO PHARMA

FEA: Ricardo Ruiz Villaverde

 

Estudio Adherencia al tratamiento a la espuma de aerosol Cal / BD tópica (Enstilar) en pacientes con psoriasis en placa, (Adherencia a Enstilar en psoriasis en placa). PSO-18-002

Promotor: LEO Pharma

FEA: Francisco J Navarro Triviño

 

Estudio retrospectivo multicéntrico de práctica clínica habitual en pacientes con psoriasis moderada a grave tratados con Guselkumab. Estudio Spring

Código de protocolo del promotor: JAN-GUS-2019-02

Investigador principal: Jose Carlos Ruiz Carrascosa

 

“Estudio multicéntrico epidemiológico observacional y descriptivo de formas raras de psoriasis pustulosas (psoriasis pustulosa generalizada, la psoriasis pustulosa palmoplantar, la acrodermatitis continua de Hallopeau y psoriasis paradójica) y eritrodérmicas.”

Versión del Protocolo: Versión 1.0 (15/Feb/2020)

Promotor: Hospital 12 de Octubre. Dra Raquel Rivera Díaz

 

Efectividad y seguridad del empleo de Brodalumab en la práctica clínica habitual. Estudio prospectivo multicéntrico. 

Promotor: Dr Antonio Sahuquillo Torralba. HOSPITAL UNIVERSITARIO Y POLITÉCNICO LA FE.

Código de protocolo del promotor: AST-BRO-2020-01

Código de protocolo AEMPS: AST-BRO-2020-01

Versión/fecha del protocolo: 06 de marzo de 2020

Psoriasis Longitudinal Assessment and Registry (PSOLAR). Registry C0168Z03. A Multicenter, Open Registry of Patients with Psoriasis Who Are Candidates for Systemic Therapy Including Biologics

Código del protocolo: ClinicalTrials.gov Identifier: NCT00508547

Promotor: Janssen Scientific Affairs, LLC

Investigador principal: Jose Carlos Ruiz Carrascosa

Co-investigador: Ricardo Ruiz-Villaverde

 

PROYECTOS DE FINANCIACION COMPETITIVA  ACTIVOS

 

Título: Búsqueda de marcadores genéticos predictores de respuesta a nuevos fármacos en el tratamiento de la psoriasis

Carácter: Nacional

Código Proyecto: EDT-SIA-2017-02

Investigador principal: Esteban Daudén Tello

Co-investigador: Ricardo Ruiz Villaverde/Jose C Ruiz Carrascosa

Dedicación: Compartida

Duracion: 2018-2021

 

Título: SELECTIVE LYMPH NODE METASTASIS RESECTION (NODE-PICKING) IN MELANOMA PATIENTS WITH LOW BURDEN LYMPH NODE METASTASIS. An EADO prospective cohort (EADO-NPco)

Carácter: Nacional

Código Proyecto:

Investigador principal: David Moreno Ramirez

Co-investigador: Francisco M Almazan Fernandez/ Ricardo Ruiz Villaverde

Dedicación: Compartida

Duracion: 2020-2023

Última Actualización de la Página: 22/06/2021 07:12:47